Pandemic Influenza Plasmid DNA Vaccines (Needle)

Summary

The trial will enroll up to 57 subjects. Qualified normal healthy volunteers will be enrolled in the study to receive the vaccine or placebo vaccine. Subjects will receive 2 vaccinations with a needle and will be followed for 6 months to evaluate the safety of and the immune system's response to the vaccine. The safety and immune system response will be studied throughout the trial.

Timeline

Start

2007-08

Primary completion

2008-09

Completion

—

Drugs

Indications